Epigenetic abnormalities and therapies for hematological malignancies

被引：0
|
作者：
Toshio Kitamura
机构：
[1] University of Tokyo,Institute of Medical Science
来源：
International Journal of Hematology | 2019年 / 110卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：147 / 149
页数：2
相关论文
共 50 条
  • [1] Epigenetic abnormalities and therapies for hematological malignancies
    Kitamura, Toshio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (02) : 147 - 149
  • [2] Histone deacetylases and epigenetic therapies of hematological malignancies
    Mercurio, Ciro
    Minucci, Saverio
    Pelicci, Pier Giuseppe
    PHARMACOLOGICAL RESEARCH, 2010, 62 (01) : 18 - 34
  • [3] Novel epigenetic therapies in hematological malignancies: Current status and beyond
    Gallipoli, Paolo
    Huntly, Brian J. P.
    SEMINARS IN CANCER BIOLOGY, 2018, 51 : 198 - 210
  • [4] Epigenetic targets in hematological malignancies: Combination therapies with HDACis and demethylating agents
    Bishton, Mark
    Kenealy, Melita
    Johnstone, Ricky
    Rasheed, Walid
    Prince, H. Miles
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (10) : 1439 - 1449
  • [5] Epigenetic dysregulation in hematological malignancies
    Iwama, Atsushi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 105 (01) : 5 - 6
  • [6] Epigenetic dysregulation in hematological malignancies
    Atsushi Iwama
    International Journal of Hematology, 2017, 105 : 5 - 6
  • [7] HEMOGLOBIN ABNORMALITIES IN HEMATOLOGICAL MALIGNANCIES
    DASGUPTA, A
    PAVRI, RS
    ADVANI, SH
    INDIAN JOURNAL OF MEDICAL RESEARCH, 1981, 73 (JAN) : 82 - 89
  • [8] Role of epigenetic changes in hematological malignancies
    Ulrich Lehmann
    Kai Brakensiek
    Hans Kreipe
    Annals of Hematology, 2004, 83 : 137 - 152
  • [9] Role of epigenetic changes in hematological malignancies
    Lehmann, U
    Brakensiek, K
    Kreipe, H
    ANNALS OF HEMATOLOGY, 2004, 83 (03) : 137 - 152
  • [10] Lysosome targeted therapies in hematological malignancies
    Manivannan, Madhumita S.
    Peters, Anthea
    Gibson, Spencer B.
    FRONTIERS IN ONCOLOGY, 2025, 15
12345